Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ola, B.
Right arrow Articles by L.R.Barratt, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ola, B.
Right arrow Articles by L.R.Barratt, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 12, 2485-2490, December 2001
© 2001 European Society of Human Reproduction and Embryology

Debates continued

Should ICSI be the treatment of choice for all cases of in-vitro conception?

Considerations of fertilization and embryo development, cost ffectiveness and safety

Bolarinde Ola, Masoud Afnan, Khaldoun Sharif, Spyros Papaioannou, Nahed Hammadieh and Christopher L.R.Barratt,1

Assisted Conception Unit, Birmingham Women's Hospital, Edgbaston, Birmingham B15 T2G, UK

There is now considerable discussion whether intracytoplasmic sperm injection (ICSI) should be used in all cases of IVF. A critical and balanced view of the current literature is presented. The difficult question is how to identify men with apparently normal semen who are likely to fail to achieve a pregnancy using IVF. In conclusion, from both the safety and scientific viewpoint, ICSI should only be used in cases where success at IVF is regarded as unlikely.

Key words: budget impact analysis/cost needed to treat/fertilization failure/intracytoplasmic sperm injection (ICSI)/number needed to treat

1 To whom correspondence should be addressed. E-mail: c.l.barratt{at}bham.ac.uk

Note added at proof

After completion of this manuscript Bhattacharya and colleagues reported on a trial comparing ICSI and IVF in non-male factor and mild male factor infertility. Although live birth rates were not reported, implantation rates were similar between the two groups (Battacharya et al., 2001).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
A. Nyboe Andersen, E. Carlsen, and A. Loft
Trends in the use of intracytoplasmatic sperm injection marked variability between countries
Hum. Reprod. Update, November 1, 2008; 14(6): 593 - 604.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
The ESHRE Capri Workshop Group
Intracytoplasmic sperm injection (ICSI) in 2006: Evidence and Evolution
Hum. Reprod. Update, November 1, 2007; 13(6): 515 - 526.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
T. Jain and R. S. Gupta
Trends in the Use of Intracytoplasmic Sperm Injection in the United States
N. Engl. J. Med., July 19, 2007; 357(3): 251 - 257.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K. L. Pixton, E. D. Deeks, F. M. Flesch, F. L.C. Moseley, L. Bjorndahl, P. R. Ashton, C. L.R. Barratt, and I. A. Brewis
Sperm proteome mapping of a patient who experienced failed fertilization at IVF reveals altered expression of at least 20 proteins compared with fertile donors: Case report
Hum. Reprod., June 1, 2004; 19(6): 1438 - 1447.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
F. Miyara, F.-X. Aubriot, A. Glissant, C. Nathan, S. Douard, A. Stanovici, F. Herve, M. Dumont-Hassan, A. L. Meur, P. Cohen-Bacrie, et al.
Multiparameter analysis of human oocytes at metaphase II stage after IVF failure in non-male infertility
Hum. Reprod., July 1, 2003; 18(7): 1494 - 1503.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. Oehninger and R. G. Gosden
Should ICSI be the treatment of choice for all cases of in-vitro conception?: No, not in light of the scientific data
Hum. Reprod., September 1, 2002; 17(9): 2237 - 2242.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.